Christopher Chapman MD - 04 Apr 2023 Form 4 Insider Report for MyMD Pharmaceuticals, Inc. (TNFA)

Role
President, Chief Med. Officer, Director
Signature
_/s/ Chris Chapman
Issuer symbol
TNFA
Transactions as of
04 Apr 2023
Net transactions value
$0
Form type
4
Filing time
05 Apr 2023, 16:28:15 UTC
Previous filing
15 Oct 2021
Next filing
09 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYMD Employee Stock Option (Right to Buy) Award $0 +750,000 $0.000000 750,000 04 Apr 2023 Common Stock 750,000 $1.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest as follows: (i) 250,000 on the date of grant; (ii) 250,000 on the first anniversary of the date of grant; and (iii) 250,000 on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date.